Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Britain's GSK and drug developer iTeos Therapeutics said on Tuesday they have stopped developing an experimental lung cancer ...

The failure is the latest stumble for a cancer drug class that hasn’t lived up to expectations. iTeos will begin a strategic ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

New research reveals how low blood sugar can damage the retina in diabetes, highlighting potential treatments targeting ...

Cytokinetics said on Tuesday its experimental heart disease drug significantly improved patients' ability to exercise compared to standard-of-care treatment in a late-stage study, sending shares of ...

GSK Plc and iTeos Therapeutics ended the development of an experimental lung cancer drug, the latest in a series of setbacks ...

A mum of four was ready to jet off with her family for the holiday of a lifetime when she got a phone call that changed ...

A nan who was given a mere five years to live after a sudden nosebleed led to an incurable cancer diagnosis has astonishingly ...

As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

After each washing, DNA sequencing of biofilm samples from inside the machines revealed the presence of potentially ...

(Reuters) -Johnson & Johnson said on Friday its experimental psoriasis drug met the main goal in a late-stage study on ...